Mechanistically, it was demonstrated that Mettl16 promotes the expression of BCAA metabolic proteins (Bcat1 and Bcat2) by adding m6A to their mRNA transcripts, further contributing to its oncogenic role in AML (Han et al., 2023). The gene discussed is METTL16; the disease is acute myeloid leukemia.